Department of Biomedical Sciences, Texas A&M Health Science Center Baylor College of Dentistry, Dallas, Texas, United States of America.
PLoS One. 2011;6(6):e21285. doi: 10.1371/journal.pone.0021285. Epub 2011 Jun 21.
We tested the hypothesis that 5-Hydroxydecanoic acid (5HD), a putative mitoK(ATP) channel blocker, will reverse sepsis-induced cardiodynamic and adult rat ventricular myocyte (ARVM) contractile dysfunction, restore mitochondrial membrane permeability alterations and improve survival.
METHODOLOGY/PRINCIPAL FINDINGS: Male Sprague-Dawley rats (350-400 g) were made septic using 400 mg/kg cecal inoculum, ip. Sham animals received 5% dextrose water, ip. The Voltage Dependent Anion Channels (VDAC1), Bax and cytochrome C levels were determined in isolated single ARVMs obtained from sham and septic rat heart. Mitochondria and cytosolic fractions were isolated from ARVMs treated with norepinephrine (NE, 10 µmoles) in the presence/absence of 5HD (100 µmoles). A continuous infusion of 5HD using an Alzet pump reversed sepsis-induced mortality when administered at the time of induction of sepsis (-40%) and at 6 hr post-sepsis (-20%). Electrocardiography revealed that 5HD reversed sepsis-induced decrease in the average ejection fraction, Simpsons+m Mode (53.5±2.5 in sepsis and 69.2±1.2 at 24 hr in sepsis+5HD vs. 79.9±1.5 basal group) and cardiac output (63.3±1.2 mL/min sepsis and 79.3±3.9 mL/min at 24 hr in sepsis+5HD vs. 85.8±1.5 mL/min basal group). The treatment of ARVMs with 5HD also reversed sepsis-induced depressed contractility in both the vehicle and NE-treated groups. Sepsis produced a significant downregulation of VDAC1, and upregulation of Bax levels, along with mitochondrial membrane potential collapse in ARVMs. Pretreatment of septic ARVMs with 5HD blocked a NE-induced decrease in the VDAC1 and release of cytochrome C.
The data suggest that Bax activation is an upstream event that may precede the opening of the mitoK(ATP) channels in sepsis. We concluded that mitoK(ATP) channel inhibition via decreased mitochondrial membrane potential and reduced release of cytochrome C provided protection against sepsis-induced ARVM and myocardial contractile dysfunction.
我们测试了 5-羟基癸酸(5HD),一种假定的线粒体 ATP 敏感性钾通道(mitoKATP)通道阻滞剂,是否可以逆转脓毒症引起的心动力学和成年大鼠心室肌细胞(ARVM)收缩功能障碍,恢复线粒体膜通透性改变,并提高存活率。
方法/主要发现:雄性 Sprague-Dawley 大鼠(350-400g)通过腹腔内注射 400mg/kg 盲肠接种物引发脓毒症。假手术动物给予 5% 葡萄糖水,腹腔内注射。在分离的来自假手术和脓毒症大鼠心脏的单个 ARVM 中测定电压依赖性阴离子通道(VDAC1)、Bax 和细胞色素 C 水平。用去甲肾上腺素(NE,10μmoles)在存在/不存在 5HD(100μmoles)的情况下处理 ARVM,分离线粒体和胞质部分。使用 Alzet 泵持续输注 5HD,在脓毒症诱导时(-40%)和脓毒症后 6 小时(-20%)给药时,可逆转脓毒症诱导的死亡率。心电图显示,5HD 逆转了脓毒症引起的平均射血分数、辛普森+M 模式(脓毒症时 53.5±2.5,脓毒症+5HD 时 24 小时 69.2±1.2,基础组 79.9±1.5)和心输出量(脓毒症时 63.3±1.2mL/min,脓毒症+5HD 时 24 小时 79.3±3.9mL/min,基础组 85.8±1.5mL/min)的降低。5HD 处理 ARVM 还逆转了在载体和 NE 处理组中脓毒症引起的收缩功能障碍。脓毒症导致 ARVM 中 VDAC1 的下调和 Bax 水平的上调,以及线粒体膜电位崩溃。脓毒症 ARVM 用 5HD 预处理可阻断 NE 诱导的 VDAC1 减少和细胞色素 C 释放。
数据表明,Bax 激活是一种上游事件,可能先于脓毒症中线粒体 ATP 敏感性钾通道的开放。我们得出结论,通过降低线粒体膜电位和减少细胞色素 C 的释放抑制 mitoKATP 通道,为脓毒症引起的 ARVM 和心肌收缩功能障碍提供了保护。